Clinical significance of expression of P-glycoprotein and bcl-2 protein in acute leukemia
WU Li-de
Abstract
WU Li-de
Abstract
Objective:To study the clinical significance of the expression of p-glycoprotein(p-gp)and bcl-2 protein in acute leukemia(AL).Methods:The expression ratios of p-gp and bcl-2 in bone marrow cells from 151 patients with AL were detected by immunohistochemistry SABC-AP.Results:The expression of p-gp was higher in the patients with refractory/relapsed acute myelogenous leukemia than that of untreated patients with AML.There was no significant difference in the positive percentage of bcl-2 between refractory/relapsed ALL patients and the untreated patients.The higher expression of p-gp and bcl-2 were observed in M5 subtype of AML.The CR rate in the patients with p-gp positive was lower than that in the patients with p-gp-(P0.05).There was no significant difference in the CR rate between the patients with bcl-2 positive and those with bcl-2 negative(P0.05).The CR rate in the patients with p-gp positive and bcl-2 positive(7.5%)was lower than that in patients with p-gp-and bcl-2 negative(91.5%)(P0.01).Conclusion:The measurement of p-gp combined with bcl-2 may be more valuable to evaluate the prognosis of acute leukemia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the clinical significance of the expression of p-glycoprotein(p-gp)and bcl-2 protein in acute leukemia(AL).Methods:The expression ratios of p-gp and bcl-2 in bone marrow cells from 151 patients with AL were detected by immunohistochemistry SABC-AP.Results:The expression of p-gp was higher in the patients with refractory/relapsed acute myelogenous leukemia than that of untreated patients with AML.There was no significant difference in the positive percentage of bcl-2 between refractory/relapsed ALL patients and the untreated patients.The higher expression of p-gp and bcl-2 were observed in M5 subtype of AML.The CR rate in the patients with p-gp positive was lower than that in the patients with p-gp-(P0.05).There was no significant difference in the CR rate between the patients with bcl-2 positive and those with bcl-2 negative(P0.05).The CR rate in the patients with p-gp positive and bcl-2 positive(7.5%)was lower than that in patients with p-gp-and bcl-2 negative(91.5%)(P0.01).Conclusion:The measurement of p-gp combined with bcl-2 may be more valuable to evaluate the prognosis of acute leukemia.
Key concepts: Medicine, Immunohistochemistry, Acute leukemia, Refractory (planetary science), Leukemia, Internal medicine, P-glycoprotein, Significant difference